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Introduction
The natural history of acute ischemic stroke (AIS) patients with large artery occlusion carries a very poor prognosis [1] . Fortunately, reperfusion therapy, i.e. intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT), extremely improves the clinical outcome in these patients [2] . Researchers keep exploring and developing the indications of reperfusion therapy. DAWN (DWI or CTP Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo) and DEFUSE 3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) trials demonstrated benefit extended to 16 to 24 hours in selected patients for EVT [3, 4] . Recently, the Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) trial also extended the time window up to 9 hours for IVT [5] .
However, a considerable part of stroke patients underwent neurological deterioration, even with timely and complete reperfusion, accompanied by severe hemorrhagic transformation and malignant brain edema. These worsening results are known as reperfusion injury [6] , which may be associated with larger infarct core and longer time from onset to treatment (OTT), based on the clinical observation. DAWN, DEFUSE 3 and EXTEND trials all had J o u r n a l P r e -p r o o f 5 approved by our local human ethics committee. All clinical investigation has been conducted according to the principles expressed in the Declaration of Helsinki. A general form of informed consent for the purposes of data collection and further investigation was obtained from all patients or their immediate family members.
Imaging parameters
MRI was performed on a 3.0T system (Signa Excite HD, General Electric Medical System, Milwaukee, USA) equipped with an 8-channel phased array head coil. DWI sequence was used to generate the apparent diffusion coefficient (ADC) map to measure the infarct core 
Evaluation of imaging and outcome
Infarct core volumes were based on a relative cerebral blood flow (CBF) lesion volume using a < 30% threshold, or a DWI lesion volume with an ADC threshold of < 620×10 -3 mm/s [7, 8] . The mismatch profile was defined as a T max > 6 seconds volume (for both CT and MR perfusion imaging) ≥ 10 mL and ≥ 120% of the infarct core volume. Acute arterial occlusion was determined by the invisibility of the artery on baseline angiography with corresponding symptoms compatible with the involved artery. According to Arterial Occlusive Lesion (AOL) scale (Grade 0: complete occlusion of the target artery; Grade 1: incomplete occlusion or partial local recanalization at the target artery with no distal flow; Grade 2: incomplete occlusion or partial local recanalization at the target artery with any distal flow; Grade 3: complete recanalization and restoration of the target artery with any distal flow) [9] , we defined recanalization with Grades 2 or 3, and no recanalization with Grades 0 or 1. Clinical outcome at 3 months was assessed with mRS and dichotomized into good outcome (0-2) and poor outcome (3-6).
Statistical analysis
Fisher's exact test was used to compare the dichotomous variables between groups, while independent samples two-tailed t-test or Mann-Whitney U test was used for the continuous variables, as appropriate. Ordinal analyses of mRS scores were performed. Variables with a 2-tailed P value of < 0.1 in univariate analyses were included in the ordinal logistic regression model. In addition, the baseline imaging method (MRI or CTP) and the treatment modality (IVT or/and EVT) were forced into the model, since they might have potential effects o n the measurement of infarct core volume and the assessment of clinical outcome. All samples were arranged in order of increasing infarct core volume. The first fifty samples were set as the first group for an ordinal analysis. Then we excluded the first five samples and included The median infarct core volume, odds ratios (ORs) and 95% confidence intervals (CIs) for each group were obtained, and then the ORs and 95% CIs were performed with natural log transformations to make the benefit curve much smoother. Thus, the log-transformed lower 95% CI > 0 was considered as clinical benefit for recanalization. Pearson's or Spearman's correlation analysis was used depending on the normality of the distribution. Partial Pearson's correlation analysis was used to adjust the potential confounds. All analyses were performed blinded to participant identifying information. Statistical significance was set at a P value of < 0.05. All statistical analyses were performed with SPSS package.
Results
A total of 445 remaining patients with intracranial ICA or M1 occlusion were included for the final analysis. The median age was 71 years (mean 69 ± 13 years, range 16-98 years) and 157 (35.3%) were women. The median baseline NIHSS score was 14 (IQR 11-18). The mean OTT was 248 ± 142 minutes (range 53-1320 minutes). 318 (71.5%) patients received CTP, and 149 (33.5%) had intracranial ICA occlusion. 158 (35.5%) patients received EVT, among whom 30 (19.0%) were mechanical only. The median baseline infarct core volume was 49 (IQR 22-85) ml. Follow-up angiography 24 hours after treatment revealed recanalization in 265 (59.6%) patients and no recanalization in 180 (40.4%) patients. The median mRS after 3 months was 4 (IQR 2-5), 3 (IQR 1-4) for patients with recanalization and 4 (IQR 3-5) for those without (p < 0.001), respectively.
The whole cohort was divided into three groups according to the time window for IVT (3 and 4.5 hours) [10] . Table 1 shows the characteristics of patients with OTT ≤ 3 hours. Patients with recanalization had lower baseline NIHSS and mRS after 3 months, higher frequency of Journal Pre-proof J o u r n a l P r e -p r o o f 8 EVT and CTP use, and lower frequency of ICA occlusion. Patients with poor outcome were older, had higher frequency of hypertension and ICA occlusion, higher baseline NIHSS, larger infarct core volume, and lower rate of recanalization. Table 2 shows the characteristics of patients with an OTT between 3 to 4.5 hours. Patients with recanalization had higher frequency of atrial fibrillation and EVT, lower rate of ICA occlusion, larger infarct core volume, and lower mRS. Patients with poor outcome were older, had higher rate of ICA occlusion, higher baseline NIHSS, larger infarct core volume, and lower rate of recanalization. Table 3 shows the characteristics of patients with OTT ≥ 4.5 hours. Patients with recanalization were older with a female predominance, had higher frequency of EVT and CTP use, and lower mRS. Patients with poor outcome were older, had higher baseline NIHSS score, and lower rate of recanalization.
There was no significant correlation between baseline infarct core volume and OTT during any time period (spearman rho = -0.093, p = 0.248, for OTT ≤ 3 hours; spearman rho = 0.056, p = 0.510, for 3 < OTT < 4.5 hours; spearman rho = -0.098, p = 0.236, for OTT ≥ 4.5 hours).
Mismatch measurements were taken from 364 patients, neither mismatch volume (partial correlation coefficient = -0.077, p = 0.144) nor ratio (partial correlation coefficient = -0.019, p = 0.724) was associated with OTT, after adjusting for baseline infarct core volume. The frequency of EVT raised from 29.9% (for OTT within 4.5 hours) to 46.9% (for OTT beyond 4.5 hours) over time (p = 0.001). In addition, CTP was performed more frequently in patients who received EVT (92.4% versus 59.9%, p < 0.001), mainly because CTP became widely used after EVT was considered as a routine treatment in our stroke center. Figure 1 shows the benefit curve of infarct core volume from recanalization with OTT ≤ 3 hours. Q uadratic curves were fitted for OR (R 2 = 0.703, F = 13.431, p < 0.001), lower 95% CI (R 2 = 0.744, F = 16.432, p < 0.001) and upper 95% CI (R 2 = 0.640, F = 10.072, p < 0.001), respectively. Patients with an OTT within 3 hours would always benefit from recanalization no matter how large the infarct core volume was. Figure 2 shows the benefit curve of infarct core volume from recanalization with an OTT between 3 to 4.5 hours. Quadratic curves were fitted for OR (R 2 = 0.827, F = 33.496, p < 0.001), lower 95% CI (R 2 = 0.784, F = 25.342, p < 0.001) and upper 95% CI (R 2 = 0.844, F = 38.016, p < 0.001), respectively. Patients with an OTT between 3 to 4.5 hours might not benefit from recanalization when the infarct core volume was larger than 123.5 ml. Figure 3 shows the benefit curve of infarct core volume from recanalization with OTT ≥ 4.5 hours. Quadratic curves were fitted for OR (R 2 = 0.614, F = 11.145, p < 0.001), lower 95% CI (R 2 = 0.622, F = 11.537, p < 0.001) and upper 95% CI (R 2 = 0.585, F = 9.882, p < 0.001), respectively. Patients with an OTT beyond 4.5 hours might not benefit from recanalization when the infarct core volume was larger than 79.5 ml.
Discussion
In the current study, we investigated the effect of infarct volume on the benefit from recanalization at different OTT, and found the benefit threshold of infarct core volume decreased over time. Our findings suggested that patients with an OTT within 3 hours would Journal Pre-proof J o u r n a l P r e -p r o o f always benefit from recanalization no matter how large the infarct volume was, whereas reperfusion therapy should be carefully considered in those with infarct volume ≥ 125 ml at OTT of 3-4.5 hours, or those with infarct volume ≥ 80 ml at OTT ≥ 4.5 hours.
Under the current guideline, no restriction on the size of infarct core volume is needed to select patients for reperfusion therapy including IVT and EVT within 6 hours, while CTP, MR-DWI, or MR perfusion is recommended to aid in patient selection for IVT between 4.5-9
hours and for EVT within 6 to 24 hours [11] , based on the results from DAWN, DEFUSE 3 and EXTEND trials [3] [4] [5] . Our findings about the time-dependent benefit threshold of infarct core volume indicated that consideration of infarct volume might not be necessary when OTT is within 3 hours, but could be helpful when OTT is beyond 3 hours, as no benefit was observed over the threshold of infarct core. Previous studies demonstrated infarct core volume to be a strong predictor for clinical outcome [12] [13] [14] [15] , and anterior circulation stroke patients with acute DWI lesion volume ≥ 70 ml had a high specificity for poor outcome, with or without therapy [13, 14] . However, clinical outcome and benefit are not always the same as patients with poor outcome can still benefit from reperfusion or recanalization. Therefore, it is critical to identify the benefit of each individual patient when faced with the decision-making of reperfusion therapy. Our benefit curves thus may provide novel evidences 
